GlaxoSmithKline PLC
NYSE:GSK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
NYSE:GSK
|
UK |
|
V
|
Volatus Aerospace Inc
XHAM:ABB
|
CA |
|
E
|
EnerSys
XBER:FDN
|
US |
|
R
|
Radian Group Inc
SWB:RAG
|
US |
|
L
|
Lagardere SA
SWB:LAG
|
FR |
|
C
|
CRH PLC
NYSE:CRH
|
IE |
|
G
|
Guotai Junan International Holdings Ltd
XBER:GUE
|
HK |
|
Choice Hotels International Inc
NYSE:CHH
|
US |
|
E
|
Enova International Inc
F:27E
|
US |
|
V
|
Volkswagen AG
WSE:VOW
|
DE |
|
S
|
Siemens Healthineers AG
DUS:SHL
|
DE |
|
W
|
Wabash National Corp
F:WA9
|
US |
|
Champion Pacific Indonesia Tbk PT
IDX:IGAR
|
ID |
|
J
|
JinkoSolar Holding Co Ltd
XBER:ZJS1
|
CN |
|
Civeo Corp
NYSE:CVEO
|
US |
Wall St Price Targets
GSK Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GSK is 56.57 USD with a low forecast of 39.55 USD and a high forecast of 77.7 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GSK's stock price target?
Price Target
56.57
USD
According to Wall Street analysts, the average 1-year price target for GSK is 56.57 USD with a low forecast of 39.55 USD and a high forecast of 77.7 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.
